One of our research priorities is to target the TWEAK-Fn14 axis as potential avenue to prevent brain metastasis, since TWEAK has been found overexpressed in the invasive front of these metastasis lesions from breast cancer patients [22]. Here, TNFRSF12A is linked to breast carcinoma.